Stock listing

Stockholm:NEWBRY Newbury Pharmaceuticals AB Aktie

Home listing (Stockholm) of Newbury Pharmaceuticals AB

Follow Newbury Pharmaceuticals AB into a list and get an email when it puts out news.

Share price · OMXSTO:NEWBRY

1.52 SEK -0.04 (-2.6%)

Close on Nov 3, 2026

Past year -27.6% · daily closes, Nov 3, 2025 – Nov 3, 2026, adjusted for splits
Day range
1.40 – 1.52 SEKNov 3, 2026
Volume
130,721 sharesNov 3, 2026
Market cap
46.20M SEKAt the close on Nov 3, 2026 · price × 30.40M shares outstanding
52-week range
0.76 – 7.88 SEKLowest and highest trades, Nov 4, 2025 – Nov 3, 2026
Traded on an average day
89,420 SEKMedian day 26,933 shares · 1 day with no trades · last 3 months, Aug 3, 2026 – Nov 3, 2026
Newbury Pharmaceuticals AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:NEWBRY · Home1.52 SEK-0.04 (-2.6%)130,7211.511.521.3951.56Close on Nov 3, 2026
Frankfurt:P52€0.14 EUR+0.05 (+55.6%)—€0.137€0.14€0.087€0.09Close on Oct 30, 2026

Daily closes

Last 3 months, Aug 3, 2026 – Nov 3, 2026 · OMXSTO:NEWBRY · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
1.52-0.04-2.6%1.511.521.395130,721
1.56-0.06-3.7%1.591.7451.4686,901
1.62+0.04+2.5%1.621.641.6028,815
1.58+0.02+1.3%1.561.651.5641,554
1.56-0.105-6.3%1.561.671.475145,475
1.665+0.065+4.1%1.6052.001.60121,902
1.60-0.055-3.3%1.611.751.2185,765
1.655-0.065-3.8%1.6751.7551.4278,506
1.72+0.01+0.6%1.591.891.59109,090
1.71-0.32-15.8%2.012.251.425345,399
2.030.000.0%1.9652.031.965525
2.03-0.05-2.4%2.022.041.979,025
2.080.000.0%2.082.082.084,365
2.08-0.11-5.0%2.132.132.0529,844
2.19-0.06-2.7%2.222.262.1427,481
2.25+0.05+2.3%2.132.252.133,895
2.20-0.01-0.5%2.202.212.147,761
2.210.000.0%2.212.212.210
2.21+0.01+0.5%2.142.212.141,175
2.20+0.08+3.8%2.122.202.0832,624
2.12-0.10-4.5%2.142.142.1010,680
2.220.000.0%2.222.222.2250
2.22-0.01-0.4%2.232.262.1088,268
2.23-0.08-3.5%2.302.312.2136,201
2.31+0.02+0.9%2.232.312.233,634
2.29+0.02+0.9%2.272.292.274,861
2.27-0.04-1.7%2.312.312.1928,871
2.31+0.01+0.4%2.242.312.241,986
2.300.000.0%2.232.382.2312,684
2.30+0.20+9.5%2.112.302.1129,250
2.10-0.15-6.7%2.172.182.1017,775
2.25-0.13-5.5%2.422.422.2318,684
2.38+0.13+5.8%2.242.382.1822,000
2.25+0.03+1.4%2.172.252.146,371
2.22-0.20-8.3%2.342.502.1273,038
2.42+0.08+3.4%2.352.422.354,647
2.34-0.16-6.4%2.512.512.347,280
2.50-0.01-0.4%2.442.502.415,826
2.51+0.14+5.9%2.382.512.3830,642
2.37+0.11+4.9%2.292.372.2921,000
2.26+0.07+3.2%2.262.262.203,351
2.19-0.21-8.8%2.312.392.1930,684
2.40-0.01-0.4%2.322.402.329,288
2.41+0.02+0.8%2.412.412.32752
2.39-0.10-4.0%2.492.492.399,442
2.49-0.02-0.8%2.512.532.4238,595
2.51+0.01+0.4%2.512.512.51105
2.50+0.02+0.8%2.482.522.1184,735
2.48-0.12-4.6%2.502.652.3853,949
2.60+0.03+1.2%2.573.472.54154,493
2.57+0.13+5.3%2.432.572.4334,630
2.44-0.30-10.9%2.742.742.38129,781
2.74+0.30+12.3%2.442.742.4460,882
2.44+0.07+3.0%2.372.442.377,158
2.37-0.22-8.5%2.502.582.3719,308
2.59+0.01+0.4%2.662.662.5117,606
2.58-0.14-5.1%2.733.002.44154,210
2.72-0.16-5.6%2.862.862.6833,540
2.88+0.16+5.9%2.762.882.6953,183
2.72+0.03+1.1%2.702.782.7031,266
2.69-0.01-0.4%2.712.712.622,987
2.700.000.0%2.702.702.6194
2.70-0.07-2.5%2.692.962.6068,077
2.77+0.04+1.5%2.732.772.6026,933
2.73-0.07-2.5%2.762.802.708,893
2.80+0.08+2.9%2.782.802.7012,517
2.72-0.08-2.9%2.812.902.6257,081
Ticker
Stockholm:NEWBRY
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
Stockholm
Currency
SEK

What changed lately

Latest news

Newbury Pharmaceuticals secures exclusive rights to a 40-product hospital portfolio in Iraq

Sep 28, 2026

Closed 2.27 (-1.7%) on Sep 28, 2026

Newbury Pharmaceuticals accelerates its neuroscience ambitions with a new partnership for Guanfacine tablets

Aug 17, 2026

Closed 2.58 (-5.1%) on Aug 17, 2026

Newbury Pharmaceuticals Secures Generic Approval for Tofacitinib Newbury

Jul 13, 2026

Closed 2.60 (+7.4%) on Jul 13, 2026

Newbury Pharmaceuticals Secures Generic Approval for Dalbavancin Newbury

Jul 10, 2026

Closed 2.42 (+0.8%) on Jul 10, 2026

Newbury Pharmaceuticals Secures Generic Approval for Palbociclib Newbury

Apr 17, 2026

Closed 1.30 (+8.3%) on Apr 17, 2026

Newbury Pharmaceuticals extends and increases loan agreement to SEK 30m, convenes EGM

Mar 26, 2026

Closed 0.998 (+8.5%) on Mar 26, 2026

Newbury Pharmaceuticals has entered into a new partnership for Prucalopride tablets

Mar 18, 2026

Closed 0.96 (-0.8%) on Mar 19, 2026

Newbury Pharmaceuticals Secures 12-Month Pazopanib Tender in Denmark

Jan 29, 2026

Closed 1.06 (+2.9%) on Jan 29, 2026

Newbury Pharmaceuticals publishes its annual report for 2024/2025

Dec 10, 2025

Closed 1.39 (-6.4%) on Dec 11, 2025

Newbury Pharmaceuticals appoints its founder Karl Karlsson as new CEO

Nov 11, 2025

Closed 2.00 (+1.8%) on Nov 11, 2025

All Newbury Pharmaceuticals AB news

Newbury Pharmaceuticals AB on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
10 in the last 12 months · 19 in all · newest Sep 28, 2026 · oldest 2025

Where Newbury Pharmaceuticals AB is listed

ListingExchangeCountryCurrency
Stockholm:NEWBRY · Home listing · This pageStockholmSwedenSEK
Frankfurt:P52FrankfurtGermanyEUR

Log in to ask 6ix AI your own questions about Newbury Pharmaceuticals AB.